RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Magnesium valproate ameliorates type 1 diabetes and cardiomyopathy in diabetic rats through estrogen receptors.

Magnesium valproate ameliorates type 1 diabetes and cardiomyopathy in diabetic rats through estrogen receptors.

Add to Collection
2018 Jan Others S Rabadiya, S Bhadada, A Dudhrejiya… - Biomedicine & …, 2018 - Elsevier

Full Author : ['Rabadiya, Samir', 'Bhadada, Shradhha', 'Dudhrejiya, Ashvin', 'Vaishnav, Devendra', 'Patel, Bhoomika']
Journal Title : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Chapter : Section3
Journal Year : 2018
Cited by : 15.0

Estrogen is known to exhibit cardioprotective and antihyperlipidemic action. Valproic acid has been shown to upregulate estrogen receptors (ERs) in breast and prostate cancer tissues. No pharmacological evaluations for magnesium valproate (MgV) so far hav..... Read More

Keywords : ["magnesium valproate ameliorate type diabetes", "estrogen receptor", "diabetic rat", "cardiomyopathy"]
PubMed Link : https://www.sciencedirect.com/science/article/pii/S0753332217342956
Google Scholar Link : https://scholar.google.com/scholar?cites=12627499014742331688&as_sdt=2005&sciodt=0,5&hl=en&num=20